AstraZeneca UK Limited v. Watson Pharmaceuticals Inc.
1:10-cv-00915
Overview
Parties
Defendant
Watson Laboratories Inc. (CT) Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Laboratories Inc. (NY) Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Laboratories Inc. (DE) Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Laboratories Inc. - Florida Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Plaintiff
Shionogi Seiyaku Kabushiki Kaisha Operating Company
Represented By
3 Attorneys ListedCounter Claimant
EGIS Pharmaceuticals PLC NPE (Individual / Inventor)
Represented By
3 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Laboratories Inc. (NV) Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Pharma Inc. Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP
MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP
Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP v. Glenmark Generics Inc. USA
AstraZeneca Pharmaceuticals LP v. Sun Pharmaceutical Industries Ltd.
AstraZeneca Pharmaceuticals LP v. Par Pharmaceutical Inc.
AstraZeneca Pharmaceuticals LP v. Sandoz Inc.
AstraZeneca Pharmaceuticals LP v. Aurobindo Pharma Limited
AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE37314
Pyrimidine derivatives
|
Filed: 1998-08-27
Issued: 2001-08-07
|
Expired (Term Ended)
Expires: 2016-01-08
|
|
|
US6858618
Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
|
Filed: 2001-11-16
Issued: 2005-02-22
|
Expired (Term Ended)
+31d PTA
Expires: 2021-12-17
|
|
|
US7030152
Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
Filed: 1999-08-31
Issued: 2006-04-18
|
Expired (Term Ended)
Expires: 2019-08-31
|
|
|
US6316460
Pharmaceutical compositions
|
Filed: 2000-08-04
Issued: 2001-11-13
|
Expired (Term Ended)
Expires: 2020-08-04
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
110
Dispositive
39
Granted
0
Denied
0
Pending / Review
110
Motions by Category
Key Dispositive Motions & Rulings